Compare MET & AME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MET | AME |
|---|---|---|
| Founded | 1863 | 1930 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.8B | 48.0B |
| IPO Year | N/A | N/A |
| Metric | MET | AME |
|---|---|---|
| Price | $78.27 | $211.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 10 |
| Target Price | $95.75 | ★ $218.00 |
| AVG Volume (30 Days) | ★ 3.3M | 1.3M |
| Earning Date | 02-04-2026 | 02-03-2026 |
| Dividend Yield | ★ 2.80% | 0.58% |
| EPS Growth | 8.29 | ★ 10.46 |
| EPS | 5.33 | ★ 6.34 |
| Revenue | ★ $71,932,000,000.00 | $7,164,270,000.00 |
| Revenue This Year | $17.72 | $6.80 |
| Revenue Next Year | N/A | $7.64 |
| P/E Ratio | ★ $15.23 | $33.78 |
| Revenue Growth | 0.83 | ★ 3.67 |
| 52 Week Low | $65.21 | $145.02 |
| 52 Week High | $88.09 | $214.60 |
| Indicator | MET | AME |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 62.71 |
| Support Level | $78.11 | $205.10 |
| Resistance Level | $83.00 | $214.60 |
| Average True Range (ATR) | 1.45 | 2.93 |
| MACD | -0.26 | 0.38 |
| Stochastic Oscillator | 5.62 | 76.76 |
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.